Understand FDA’s Push to Build Quality into the Clinical Trial Process through Proactive Compliance, Instead of Leveraging Inspections to Trigger Quality Measures FDA (invited)
Understand what it means to build in quality
Examine recent inspection finding trends and how they relate to quality by design
Discuss proactive actions organizations can take to showcase risk management practices, to expedite or even eliminate the need for an inspection
